Urology
Volume 57, Issue 4, Supplement 1 , Pages 31-38 , April 2001

Similarities of prostate and breast cancer: Evolution, diet, and estrogens

  • Donald S Coffey

      Affiliations

    • James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA
    • Corresponding Author InformationReprint requests: Donald S. Coffey, Ph.D., James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287-2101

References 

  1. Armstrong BE, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer. 1975;15:617–631
  2. Buell P. Changing incidence of breast cancer in Japanese American women. J Natl Cancer Inst. 1973;51:1479–1483
  3. In:  Griffiths K,  Morton MS,  Denis LJ editor. Diet and Prostate Disease. Oxford, United Kingdom: International Prostate Health Council; 1998;
  4. Lopez-Otin C, Diamandis EP. Breast and prostate cancer (an analysis of common epidemiological, common genetic, common and biochemical features). Endocrinol Rev. 1998;19:365–396
  5. Prentice RL, Sheppard L. Dietary fat and cancer (consistency of the epidemiological data, and disease prevention that may follow from a practical reduction in fat consumption). Cancer Causes Control. 1990;1:81–97
  6. Cancer Facts and Figures, 2000. Atlanta, GA, American Cancer Society, 2000.
  7. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption. Cancer. 1986;58:2363–2371
  8. Haenszel W, Kurihoro M. Studies of Japanese migrants. J Natl Cancer Inst. 1968;40:43–68
  9. Shimizu H, Ross RK, Bernstein L, et al.  Cancer of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991;63:963–966
  10. Willets WC. Specific fatty acids and risks of breast and prostate cancer (dietary intake). Am J Clin Nutr. 1997;66(suppl 6):15575–15635
  11. Benoit RM, Naslund MJ. Detection of latent prostate cancer from routine screening (comparison with breast screening). Urology. 1995;46:533–536
  12. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate. 1989;2(suppl):33–50
  13. Walsh PC, Wilson JD. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest. 1976;57:1093–1097
  14. DeKlerk DP, Coffey DS, Ewing LL, et al.  Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1979;64:842–849
  15. Coffey DS, Walsh PC. Clinical experimental studies of benign prostatic hyperplasia. Urol Clin North Am. 1990;17:461–475
  16. Raijfer J, Coffey DS. Sex steroid imprinting of the immature prostate—long term effects. Invest Urol. 1978;16:186–189
  17. Naslund MJ, and Coffey DS: The hormonal imprinting of the prostate and the regulation of stem cells in prostatic growth, in Rogers CH, Coffey DS, Cunha G, et al (Eds): Benign Prostatic Hyperplasia, vol II; Bethesda, MD, US Department of Health and Human Services 1987:73–83. NIH Publication 87-2881.
  18. Naslund MJ, Coffey DS. The differential effects of neonatal androgens, estrogens and progesterone on adult rat prostate growth. J Urol. 1986;136:1136–1140
  19. Prins GS. Neonatal estrogen exposure induces low-specific alterations in adult rat prostate androgen receptor expression. Endocrinology. 1998;130:874–883
  20. Prins GS, Marmer M, Woodham C, et al.  Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology. 1998;138:874–883
  21. Sharma OP, Adlercrueutz H, Strandberg JD, et al.  Soy and dietary sources play a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol. 1992;43:557–564
  22. Stoll BA. Eating to beat breast cancer (potential role for soy supplements). Ann Oncol. 1997;8:223–225
  23. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein (emerging role for its effects via transforming growth factor beta signaling pathways). Am J Clin Nutr. 1998;68:1418S–1425S
  24. DeMarzo AM, Nelson WG, Meeker AK, et al.  Stem cell features of benign and malignant prostatic epithelial cells. J Urol. 1998;160:2381–2392
  25. DeMarzo AM, Marchi V, Epstein JI, et al.  Proliferative inflammatory atrophy of the prostate (implication for prostatic carcinogenesis). Am J Pathol. 1999;155:1985–1992
  26. DeMarzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology. 1999;53(suppl 3A):29–40
  27. Oberley TD, Zhong W, Szweda LI, et al.  Localization of antioxidant enzymes and oxidative damage products in normal and malignant cells. Prostate. 2000;44:144–155
  28. Malins DC, Polissar NL, Gunselman SJ. Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc Natl Acad Sci USA. 1997;94:259–264
  29. Getzenberg RH, Pienta KJ, Coffey DS. The tissue matrix (cell dynamics in hormone action). Endocrinol Rev. 1990;11:399–417
  30. Darwin C. On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life. London: John Murray; 1859;

PII: S0090-4295(00)00938-9

Urology
Volume 57, Issue 4, Supplement 1 , Pages 31-38 , April 2001

Article Tools

* Image Usage & Resolution